Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells (Q40786697)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells (English)

1 reference

Europe PubMed Central

23 September 2017

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Brockhoff G

1

1 reference

Europe PubMed Central

23 September 2017

Heiss P

2

1 reference

Europe PubMed Central

23 September 2017

Schlegel J

3

1 reference

Europe PubMed Central

23 September 2017

Hofstaedter F

4

1 reference

Europe PubMed Central

23 September 2017

Knuechel R

5

1 reference

Europe PubMed Central

23 September 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

23 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

23 September 2017

44

1 reference

Europe PubMed Central

23 September 2017

4

1 reference

Europe PubMed Central

23 September 2017

338-348

1 reference

Europe PubMed Central

23 September 2017

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Switching signals on or off by receptor dimerization

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Role of HER2 gene overexpression in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

The type I growth factor receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Therapy of metastatic breast cancer with humanized antibodies against the HER2 receptor protein.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Importance of tyrosine phosphatases in the effects of cell‐cell contact and microenvironments on EGF‐stimulated tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Overexpression of the c-erbB-2 protein in human breast tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Only one of the two signals required for initiation of the cell cycle is associated with cellular accumulation of ribosomal RNA

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Zwischenmolekulare Energiewanderung und Fluoreszenz

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Regulation of signal transduction and signal diversity by receptor oligomerization

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

p185HER2 overexpression in human breast cancer using molecular and immunohistochemical methods

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Evaluation of flow-cytometric three-parameter analysis for EGFR quantification and DNA assessment in human bladder carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Solution structure of the SH2 domain of Grb2/Ash complexed with EGF receptor-derived phosphotyrosine-containing peptide

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Flow cytometric detection and quantitation of the epidermal growth factor receptor in comparison to Scatchard analysis in human bladder carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

c-erbB-2 oncoprotein is not an independent prognostic parameter in primary breast carcinoma. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Identifiers

10.1002/1097-0320(20010801)44:4<338::AID-CYTO1125>3.0.CO;2-V

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40786697&oldid=2039017853"